EDGAR Filing Documents for 0000320017-15-000065

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000320017-15-000065

Filing Date

2015-08-06

Accepted

2015-08-06 17:02:04

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	clbs-10qx20150630.htm	10-Q	1147001
2	EXHIBIT 3.2	exhibit31amendarticles.htm	EX-3.2	10175
3	EXHIBIT 10.1	exhibit101lsaamendment.htm	EX-10.1	41673
4	EXHIBIT 31.1	clbs-ex311_20150630xq2.htm	EX-31.1	9172
5	EXHIBIT 31.2	clbs-ex312_20150630xq2.htm	EX-31.2	9253
6	EXHIBIT 32.1	clbs-ex321_20150630xq2.htm	EX-32.1	8459
7	EXHIBIT 32.2	clbs-ex322_20150630xq2.htm	EX-32.2	8496
	Complete submission text file	0000320017-15-000065.txt		6687314

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	clbs-20150630.xml	EX-101.INS	1329907
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	clbs-20150630.xsd	EX-101.SCH	52004
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	clbs-20150630_cal.xml	EX-101.CAL	90582
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	clbs-20150630_def.xml	EX-101.DEF	338109
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	clbs-20150630_lab.xml	EX-101.LAB	688938
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	clbs-20150630_pre.xml	EX-101.PRE	403254

Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171

Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)